Conf42 DevOps 2025 - Online

- premiere 5PM GMT

Combatting Antibiotic Resistance in UTI Treatment: Phase 3 Insights on Sulopenem vs. Ciprofloxacin

Abstract

Discover how we’re revolutionizing UTI treatment in the fight against antibiotic resistance! Learn about sulopenem’s groundbreaking success against multi-drug resistant pathogens, offering hope where other antibiotics fail. Join us for game-changing insights into the future of infection management!

...

Karthik Akinapelli

Associate Director, Statistical Programing @ Takeda

Karthik Akinapelli's LinkedIn account



Join the community!

Learn for free, join the best tech learning community for a price of a pumpkin latte.

Annual
Monthly
Newsletter
$ 0 /mo

Event notifications, weekly newsletter

Delayed access to all content

Immediate access to Keynotes & Panels

Community
$ 8.34 /mo

Immediate access to all content

Courses, quizes & certificates

Community chats

Join the community (7 day free trial)